Guardian Pharmacy Services, Inc. reported its financial results for the second quarter of 2026, revealing a revenue increase of 2.2% to $351.8 million compared to $344.3 million in the same period of 2025. For the first half of 2026, revenue rose to $688.4 million from $673.6 million in the prior year. The company’s net income for the second quarter surged to $22.1 million, up from $8.8 million in the previous year, while net income for the first half reached $35.7 million, compared to $18.1 million in 2025. This significant growth in profitability was attributed to improved operational efficiencies and a favorable legal settlement that contributed $8.5 million to other income.
The company experienced notable changes in its operational metrics, with the number of residents served increasing from 195,000 in June 2025 to 210,000 in June 2026. Additionally, prescriptions dispensed rose from 7.0 million to 7.6 million during the same period. Despite these increases, organic revenue decreased due to pricing pressures stemming from the Inflation Reduction Act (IRA), which impacted drug pricing and reimbursement rates. The company’s cost of goods sold also decreased by 1.6% in the second quarter, reflecting a shift in product costs due to the IRA.
Strategically, Guardian Pharmacy Services has focused on growth through acquisitions, completing several pharmacy operations acquisitions in 2025. The integration of these acquisitions contributed to the revenue growth reported in the latest quarter. The company also executed a follow-on public offering in March 2026, raising capital to support its growth initiatives. As of June 30, 2026, Guardian operated 61 pharmacies across 39 states, with a significant portion of its revenue derived from long-term care facilities, particularly assisted living and behavioral health facilities.
The company’s financial position remains strong, with total assets increasing to $443.6 million as of June 30, 2026, up from $412.7 million at the end of 2025. Cash and cash equivalents also rose to $89.8 million, providing a solid liquidity position to support ongoing operations and potential future acquisitions. The company reported a decrease in total liabilities to $185.9 million, reflecting effective management of its financial obligations.
Looking ahead, Guardian Pharmacy Services anticipates continued growth driven by its strategic focus on expanding its resident base and enhancing service offerings. However, the company acknowledges the ongoing challenges posed by regulatory changes and market conditions, particularly those related to drug pricing reforms. Management remains committed to navigating these challenges while leveraging its operational strengths to sustain growth and profitability in the long term.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. provides technology-enabled pharmacy services tailored for long-term care facilities, including assisted living and behavioral health settings. It specializes in medication management, compliance packaging, clinical support, and data analytics to improve resident outcomes, reduce errors, and lower healthcare costs. Serving approximately 186,000 residents across 7,000 LTCFs nationwide, it leverages automation, local management, and strategic growth to maintain a competitive position in the institutional pharmacy market.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov